.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer last year for an enormous $43 ...
.On the heels of a stage 3 succeed that stopped working to blow away clients, Ironwood Pharmaceutica...
.Don't cease Monte Rosa Therapies right now. The Boston-based biotech is having a ball after authori...
.Accept to today's Chutes & Ladders, our roundup of considerable leadership hirings, shootings an...
.Celebrating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer called the openin...
.AbbVie has come back to the source of its antipsychotic powerhouse Vraylar looking for another runa...
.GenSight Biologics is full weeks out of losing cash. Once again. The biotech simply possesses adequ...
.Monopar Rehabs is bouncing back a medicine from the scrap heap of AstraZeneca's unusual health cond...
.With brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of analyst...
.After creating a genetics treatment relationship with Dyno Rehabs in 2020, Roche is back for more.I...
.Lundbeck is actually lowering guide worth of its $250 million Abide Rehabs buyout in reaction to st...
.The assimilation of real-world records (RWD) right into procedure feasibility as well as website va...
.At this year's Fierce Biotech Top in Boston, our company overtook innovators in the biotech busines...
.Merck & Co. is putting down $30 thousand ahead of time to purchase Yale spinout Modifi Bioscienc...
.Alpha-9 Oncology has increased a $175 million set C cycle to money its own clinical-stage radiophar...
.Eye medicine creator Ocuphire Pharma is actually obtaining genetics therapy creator Opus Genetic ma...
.Roche's persistent coughing course has actually faltered to a halt. The drugmaker, which axed the c...
.Gilead Sciences and also Merck & Co. have actually helped their once-weekly HIV mixture therapy ...
.Lykos Rehabs might possess shed three-quarters of its staff in the wake of the FDA's being rejected...
.Septerna might be actually yet to divulge "any relevant professional records," but the biotech accu...